Results

Total Results: 744 records

Showing results for "presence".

341. medication-assisted-treatment-protocol-160224 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/opioid-use-disorder_research-protocol.pdf
     February 24, 2016 - .10 Challenges in the treatment of OUD include the relapsing nature of this condition, the frequent presence

342. Comparative Effectiveness of Therapies for Women with Noncyclic Chronic Pelvic Pain (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/pelvic-pain_disposition-comments.pdf
     January 01, 2012 - Typically, endometriosis studies would define endometriosis as the presence of glands and stroma without

343. Lysosomal-Storage-Diseases-Therapies Research-Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/lysosomal-storage-diseases-therapies_research-protocol.pdf
     November 15, 2012 - before-after studies, case During the Topic Refinement phase of this project, we did not anticipate the presence

344. Evidence-based Practice Center Systematic Review Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/rotator-cuff-tear_disposition-comments.pdf
     October 05, 2010 - The following statement describes the use of clinical examination in determining the presence of an

345. Microsoft Word - Comp Eff 10.doc (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/ace-inhibitor-arb-2007_research-2007-1.pdf
     January 01, 2007 - ACEIs, for example, do not entirely block production of angiotensin II because of the presence of unaffected … ACEIs, for example, do not entirely block production of angiotensin II due to the presence of unaffected … Presence of food reduces absorption by 30-40%. … In the presence of statistical heterogeneity, we evaluated likely explanatory clinical and methodological … , studies appeared to be clinically and methodologically similar, we performed pooling even in the presence

346. Implementing Evidence-Based Screening and Counseling for Unhealthy Alcohol-Use With Epic-Based Electronic Health Record Tools: A Guide for Clinics and Health Systems Developed as Part of a Pilot Dissemination Project (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/implementation-package-unhealthy-alcohol-use-final.pdf
     September 01, 2018 - staff and provider familiarity and agreement with the rationale and tools for implementation, the presence … staff and provider familiarity and agreement with the rationale and tools for implementation, the presence

347. Depression-Postpartum-Screening Executive (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/depression-postpartum-screening_executive.pdf
     May 01, 2013 - Although the presence of any of these risk factors would presumably improve the positive predictive … therapeutic services; the USPSTF recommendations explicitly separate the recommendations based on the presence

348. Disposition of Comments_Systematic Review_Trauma Informed Care: A Systematic Review (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/trauma-informed-care-disposition-comments.pdf
     January 14, 2025 - Further, we explain that the presence of at least one patient-level health outcome was needed to be

349. Association Between Outcomes and Dental Services in People With Substance Use Disorder: A Rapid Response Review (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/outcomes-dental-services-rapid-research.pdf
     May 01, 2025 - to 2.2 and 2.3, or N/PN to 2.4, were adjustment techniques used that are likely to correct for the presence … -- 5.5 If PN/N to 5.1 or Y/PY to 5.2 or 5.3, is there evidence that results were robust to the presence

350. Masks-Surveillance-2-Appendix-Table-A-1 (xls file)
     effectivehealthcare.ahrq.gov/sites/default/files/masks-surveillance-2-appendix-table-a-1.xlsx
     April 09, 2020 - medical condition (yes vs. no): 65.4% (89/136) vs. 55.5% (562/1013), RR 1.18 (95% CI 1.03 to 1.35) Presence … 95% CI 0.97 to 1.32) Multivariate model Cloth vs. medical mask: adjusted RR 1.02 (95% 0.97 to 1.08) Presence

351. Masks-Appendix-Table-B-1-Version-2 (xls file)
     effectivehealthcare.ahrq.gov/sites/default/files/masks-appendix-table-b-1-version-2.xlsx
     April 09, 2020 - medical condition (yes vs. no): 65.4% (89/136) vs. 55.5% (562/1013), RR 1.18 (95% CI 1.03 to 1.35) Presence … 95% CI 0.97 to 1.32) Multivariate model Cloth vs. medical mask: adjusted RR 1.02 (95% 0.97 to 1.08) Presence

352. Masks-Appendix-Table-B-1-Surveillance-Report (xls file)
     effectivehealthcare.ahrq.gov/sites/default/files/Masks-appendix-table-b-1-surveillance-report.xlsx
     April 09, 2020 - medical condition (yes vs. no): 65.4% (89/136) vs. 55.5% (562/1013), RR 1.18 (95% CI 1.03 to 1.35) Presence … 95% CI 0.97 to 1.32) Multivariate model Cloth vs. medical mask: adjusted RR 1.02 (95% 0.97 to 1.08) Presence

353. Appendix Table B-1. RCTs of Masks (xls file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/masks-appendix-table-b-1-version-1.xlsx
     April 09, 2020 - medical condition (yes vs. no): 65.4% (89/136) vs. 55.5% (562/1013), RR 1.18 (95% CI 1.03 to 1.35) Presence … 95% CI 0.97 to 1.32) Multivariate model Cloth vs. medical mask: adjusted RR 1.02 (95% 0.97 to 1.08) Presence

354. Treatments and Technologies Supporting Appropriate Opioid Tapers | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/appropriate-opioid-tapers/research

355. Protocol for Quantitative Assessment of Benefit and Harm analysis of Aspirin for primary prevention (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/methods-balancing-harms-benefits_research.pdf
     February 01, 2014 - For example, for a patient of a certain age, sex, and with presence or absence of risk factors for the … However, one must be careful that, in the presence of heterogeneity of treatment effects, the average … Evaluating health outcomes in the presence of competing risks: a review of statistical methods and

356. Venous-Ulcers-Treatment-Future Research (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/venous-ulcers-treatment-future_research.pdf
     January 01, 2014 - duration, history of recurrence of lesions over time, and appearance of the ulcer base (dry versus presence … of excessive moisture, hemorrhagic versus avascular, presence of fibrosis around the rim). … be a standardized method of evaluating the condition of the wound bed to consistently report on the presence … • Outcome: Important outcomes include quality of the wound bed (amount of necrotic tissue and/or presence

357. Serum Free Light Chain Analysis for the Diagnosis, Management, and Prognosis of Plasma Cell Dyscrasias: Future Research Needs (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/plasma-cell-dyscrasias-sflc-assay-future_research.pdf
     September 01, 2012 - set of patient data with regard to response status, and therapeutic approach in the absence and presence … SFLC results), with physicians surveyed about what treatment decisions would be in the absence and presence … a set of patient data with regard to response status, and therapeutic approach in the absence and presence … SFLC results), with physicians surveyed about what treatment decisions would be in the absence and presence

358. Evidence-based Practice Center Systematic Review Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/disabilities-quality-improvement-outcomes_research-protocol.pdf
     August 03, 2011 - Medical problems can be exacerbated or complicated by the presence of other problems, including medical

359. S116 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/s116.pdf
     October 01, 2007 - Instrumental variable methods allow for the estima- tion and bounding of treatment effects in the presence

360. CER 215 Executive Summary: Adverse Effects of Pharmacologic Treatments of Major Depression in Older Adults (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-215-depression-older-adults-executive-summary.pdf
     March 01, 2019 - According to a single post-hoc analysis on a RCT, risk of falls on duloxetine may be associated with the presence